scout

Podcasts

Recent Episodes

Experts discussed supportive care and why it should be integrated into standard oncology care.
How Supportive Care Methods Can Improve Oncology Outcomes
Experts highlight the top 5 presentations from ESMO 2025 that may have long-term clinical implications for genitourinary cancer management.
What Were The Most Impactful GU Oncology Data From ESMO 2025?
Three GI cancer medical oncologists discuss the most significant abstracts in GI cancers from the 2025 ESMO Congress.
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
Presenting investigators at ESMO Congress 2025 highlight findings from clinical trials assessing novel therapeutics across different disease types.
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
“Paradigm-changing events” are occurring across the small cell lung cancer field in real time, according to Anne Chiang, MD, PhD.
Leveraging Biology to Advance the Small Cell Lung Cancer Treatment Paradigm
Experts highlight anticipated sessions at the 2025 ESMO Congress, including those on the PSMAddition and EV-303 trials.
Exploring the ESMO 2025 Presentations That May Shift GU Oncology
Jorge Cortes, MD, outlines the impact of imatinib in chronic myeloid leukemia and highlights future initiatives in the field.
Charting the Evolution of TKIs and Finding the Next Breakthrough in CML
A panel of oncology pharmacists discusses the role of lifileucel in metastatic melanoma and other considerations for using cellular therapy in solid tumors.
Optimizing Care for TILs, Cellular Therapy in Melanoma and Solid Tumors
Prospective data observed with the gemcitabine intravesical system may be superior to prior reports of other therapies in BCG-unresponsive NMIBC.
Gemcitabine Intravesical System Offers Tremendous Benefits in NMIBC
Experts discuss key considerations for applying ctDNA to clinical practice, such as distinguishing between tumor-informed and tumor-uninformed testing.
Diving Into the Practical Applications of ctDNA in Oncology Care

All series

Experts discussed supportive care and why it should be integrated into standard oncology care.

Recent Episodes

A panel of oncology pharmacists discusses the role of lifileucel in metastatic melanoma and other considerations for using cellular therapy in solid tumors.

Oncology On the Go With ASTCT Talks

Experts highlight the top 5 presentations from ESMO 2025 that may have long-term clinical implications for genitourinary cancer management.

ONCOLOGY Decoded

Prospective data observed with the gemcitabine intravesical system may be superior to prior reports of other therapies in BCG-unresponsive NMIBC.

FDA Approval Alert: The Need-to-Know

Oncology-on-the-Go with Daniel C. McFarland, DO

Oncology-on-the-Go with Daniel C. McFarland, DO

Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us